Contrast Enhanced Ultrasound (CEUS) in Atypical Liver Nodules in Patients With Chronic Liver Disease

Fondazione Policlinico Universitario Agostino Gemelli IRCCS100 enrolled

Overview

The present study aims to investigate the role of CEUS in evaluating liver lesions with atypical characteristics on contrast-enhanced CT or MRI. All patients enrolled in the study underwent contrast-enhanced ultrasound. Based on CEUS characteristics, atypical nodules will be categorized according to CEUS LI-RADS classification.

This retrospective study investigates the role of CEUS in evaluating liver lesions with atypical characteristics on contrast-enhanced CT or MRI. All patients enrolled in the study underwent contrast-enhanced ultrasound. All CEUS exams were performed, recorded, and analyzed by two experienced operators (\>10 years of experience with abdominal US and CEUS). Based on CEUS characteristics, atypical nodules will be categorized according to CEUS LI-RADS (LR) classification. If the analyzed nodule shows a typical hallmark on CEUS (LR-5), that is arterial phase hyperenhancement with late-onset (\>60 s) washout of mild intensity, it is definitively considered HCC and have been treated appropriately. Categories LR-3 and LR-4 comprise nodules with different combinations of arterial and venous phase enhancement features, expected to correspond to an intermediate or high probability of lesions to be HCC. Patients with LR-3 or LR-4 nodules underwent follow-up; in some cases they underwent biopsy. LR-M is used to classify high-probability malignant lesions but nonspecific for HCC; these nodules underwent biopsy for further characterization.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Hepatocellular Carcinoma

Interventions

CEUSDIAGNOSTIC_TEST

CEUS for atypical liver nodules

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * diagnosis of liver cirrhosis or chronic liver disease with increased risk of HCC * diagnosis of atypical nodules on contrast-enhanced CT or MRI Exclusion Criteria: * less than 18 years of age * pregnancy * typical nodules on contrast-enhanced CT or MRI * non-visualized nodule on B-mode US * CEUS not performed or performed more than three months after CT or MRI

Locations (1)

Fondazione Policlinico A Gemelli Irccs

Roma, RM, Italy

Outcomes

Primary Outcomes

The role of CEUS in evaluating atypic liver lesions on contrast-enhanced CT or MRI.

The primary endpoint is to assess the contrastographic behaviour of nodules suspected of HCC and defined as atypical by contrast-enhanced CT and MRI, using CEUS. Prevalence of CEUS LI-RADS categories among atypical nodules will be described.

Time frame: Between January 2018 and January 2023

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.